Document Detail


Different effects of metoprolol and chlorthalidone on serum lipoprotein levels in mild hypertension. Possible implications for coronary heart disease risk status.
MedLine Citation:
PMID:  6519949     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effects of chlorthalidone and metoprolol on fasting plasma lipids and lipoprotein levels were compared in two similar nonrandomized groups of patients with mild hypertension. Chlorthalidone therapy was associated with an increase in serum cholesterol of 8.1% (17 mg/dl), mainly reflecting an increase in low-density lipoprotein (LDL)-cholesterol. High-density lipoproteins (HDL)-cholesterol decreased, but the difference between pre- and posttreatment levels did not reach statistical significance. Serum triglyceride (TG) concentration increased by 16% (20 mg/dl). Metoprolol therapy was not associated with changes in total, very low-density lipoprotein (VLDL)-, LDL- and HDL-cholesterol levels. Serum TG concentration increased by 22% (28 mg/dl), mainly due to an increase in VLDL-TG. Application of the Israel Ischemic Heart Disease Study data to these findings could predict only a very slight decrease in the 5-year estimated probability of myocardial infarction in the chlorthalidone-treated group. Metoprolol therapy has, theoretically, a more favorable influence on coronary heart disease risk status. These data suggest that the different forms of therapy for mild hypertension have a different effect on the theoretical coronary heart disease risk status, a fact that should be taken into consideration in the choice of medication.
Authors:
E Holtzman; T Rosenthal; U Goldbourt; P Segal
Related Documents :
25149379 - Effect of phentolamine on myocardial extracellular matrix of cardiac remodeling in rats.
11575709 - A clinical focus on statins.
3094999 - The predictive value of lipid studies in patients undergoing cardiac catheterization an...
15159039 - A comparison of hdl and ldl cholesterol for prevalent coronary calcification.
7819429 - Vitamin e compared with other potential risk factor concentrations in patients with and...
11115459 - Plasma homocysteine and severity of thoracic aortic atherosclerosis.
8519009 - Acute myocardial infarction without warning: clinical characteristics and significance ...
1843619 - Myocardial necrosis in a newborn after long-term maternal subcutaneous terbutaline infu...
15847029 - Troponins: current status in coronary artery disease.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Israel journal of medical sciences     Volume:  20     ISSN:  0021-2180     ISO Abbreviation:  Isr. J. Med. Sci.     Publication Date:  1984 Dec 
Date Detail:
Created Date:  1985-02-25     Completed Date:  1985-02-25     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0013105     Medline TA:  Isr J Med Sci     Country:  ISRAEL    
Other Details:
Languages:  eng     Pagination:  1169-76     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Body Weight
Chlorthalidone / adverse effects*
Cholesterol / blood
Coronary Disease / etiology*
Female
Heart Rate
Humans
Hypertension / blood,  drug therapy*
Lipoproteins / blood*
Male
Metoprolol / adverse effects*
Middle Aged
Triglycerides / blood
Chemical
Reg. No./Substance:
0/Lipoproteins; 0/Triglycerides; 37350-58-6/Metoprolol; 57-88-5/Cholesterol; 77-36-1/Chlorthalidone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Screening for early detection of radiation-associated thyroid cancer: a pilot study.
Next Document:  Ventricular tachycardia induced by slow ventricular pacing.